StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BIAF

bioAffinity Technologies, Inc.

BIAF Nasdaq Services-Commercial Physical & Biological Research EDGAR ↗
$0.60
-0.05 -7.24%

Key statistics

from XBRL data in SEC filings
Market cap
$2.71M
Revenue (TTM)
$5.66M
Net income (TTM)
-$15.9M
EPS (TTM)
$-4.67
P/E ratio
Dividend yield
Free cash flow
-$9.39M
Cash
$3.10M
Total assets
$7.95M
Gross margin
4.3%
52-week range
$0.56 – $13.50

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Delisting notice or listing-rule failure Jul 31, 2026 8-K Other events Jul 27, 2026 8-K Other events Jul 22, 2026 8-K Other events Jul 7, 2026 8-K Other events Jun 30, 2026 8-K Entered a material agreement; Other events Jun 18, 2026 8-K Other events Jun 16, 2026 8-K Other events Jun 2, 2026 8-K Other events May 27, 2026 8-K Other events May 12, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) May 8, 2026 8-K Director or officer change; Shareholder vote results Apr 30, 2026 8-K Other events Apr 14, 2026 8-K Other events Apr 7, 2026 8-K Other events Apr 1, 2026 8-K Regulation FD disclosure Mar 26, 2026 8-K Other events Mar 25, 2026 8-K Other events Mar 17, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Results of operations (earnings release) Mar 13, 2026 8-K Other events Mar 10, 2026 8-K Director or officer change Mar 6, 2026 8-K Other events Mar 3, 2026 8-K Other events Feb 25, 2026 8-K Other events Feb 19, 2026 8-K Other events Feb 17, 2026 8-K Regulation FD disclosure Feb 10, 2026 8-K Other events Feb 9, 2026 8-K Other events Feb 4, 2026 8-K Other events Jan 7, 2026 8-K Other events Dec 22, 2025 8-K Other events Dec 19, 2025 8-K Other events Dec 3, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Other events Nov 5, 2025 8-K Other events Oct 28, 2025 8-K Other events Oct 20, 2025 8-K Other events Oct 16, 2025